Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Atyr Pharma Inc (ATYR) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Atyr Pharma Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1339970.
Total stock buying since 2015: $16,426,744.
Total stock sales since 2015: $3,198,951.
Total stock option exercises since 2015: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 3,750 | $15,000 | 2,153 | $8,138 | 16,812 | $0 |
| 2024 | 130,000 | $238,992 | 1,590 | $2,687 | 16,813 | $0 |
| 2023 | 245,000 | $514,574 | 1,566 | $3,695 | 46,813 | $0 |
| 2022 | 31,923 | $111,365 | 0 | $0 | 0 | $0 |
| 2021 | 312,500 | $2,260,537 | 3,668 | $19,796 | 2,677 | $0 |
| 2020 | 261,850 | $1,112,925 | 24,889 | $97,628 | 3,571 | $0 |
| 2019 | 0 | $0 | 4,651 | $2,092 | 12,500 | $0 |
| 2018 | 839,385 | $557,471 | 3,212,120 | $3,008,444 | 10,001 | $0 |
| 2017 | 164,355 | $501,350 | 13,832 | $56,471 | 0 | $0 |
| 2016 | 467,752 | $1,454,530 | 0 | $0 | 0 | $0 |
| 2015 | 690,000 | $9,660,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-03 | 3,750 | $15,000 | 0 | $0 | 0 | $0 |
| 2025-02 | 0 | $0 | 2,153 | $8,138 | 16,812 | $0 |
| 2024-07 | 100,000 | $184,627 | 0 | $0 | 0 | $0 |
| 2024-06 | 5,000 | $9,275 | 0 | $0 | 0 | $0 |
| 2024-05 | 25,000 | $45,090 | 0 | $0 | 0 | $0 |
| 2024-02 | 0 | $0 | 1,590 | $2,687 | 16,813 | $0 |
| 2023-12 | 15,000 | $17,646 | 0 | $0 | 0 | $0 |
| 2023-11 | 15,000 | $16,703 | 0 | $0 | 0 | $0 |
| 2023-07 | 15,000 | $30,225 | 0 | $0 | 0 | $0 |
| 2023-05 | 200,000 | $450,000 | 0 | $0 | 0 | $0 |
| 2023-04 | 0 | $0 | 0 | $0 | 30,000 | $0 |
| 2023-02 | 0 | $0 | 1,566 | $3,695 | 16,813 | $0 |
| 2022-11 | 10,000 | $21,410 | 0 | $0 | 0 | $0 |
| 2022-07 | 15,000 | $43,170 | 0 | $0 | 0 | $0 |
| 2022-01 | 6,923 | $46,785 | 0 | $0 | 0 | $0 |
| 2021-11 | 2,500 | $21,437 | 0 | $0 | 0 | $0 |
| 2021-09 | 250,000 | $2,000,000 | 0 | $0 | 0 | $0 |
| 2021-05 | 60,000 | $239,100 | 2,500 | $10,850 | 0 | $0 |
| 2021-02 | 0 | $0 | 1,168 | $8,946 | 2,677 | $0 |
| 2020-09 | 0 | $0 | 7,260 | $29,112 | 0 | $0 |
| 2020-08 | 0 | $0 | 7,740 | $32,100 | 0 | $0 |
| 2020-06 | 7,850 | $33,425 | 0 | $0 | 0 | $0 |
| 2020-05 | 0 | $0 | 8,769 | $31,903 | 892 | $0 |
| 2020-02 | 254,000 | $1,079,500 | 1,120 | $4,513 | 2,679 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-17 | Gross Jane A | Buy | 3,750 | 4.00 | 15,000 |
| 2025-02-04 | Denyes Nancy (General Counsel) | Sale | 899 | 3.78 | 3,398 |
| 2025-02-04 | Broadfoot Jill Marie (Chief Financial Officer) | Sale | 1,254 | 3.78 | 4,740 |
| 2025-02-03 | Shukla Sanjay (President and CEO) | Option Ex | 10,375 | .00 | 0 |
| 2025-02-03 | Denyes Nancy (General Counsel) | Option Ex | 2,687 | .00 | 0 |
| 2025-02-03 | Broadfoot Jill Marie (Chief Financial Officer) | Option Ex | 3,750 | .00 | 0 |
| 2024-07-24 | Schimmel Paul | Buy | 52,300 | 1.93 | 101,043 |
| 2024-07-23 | Schimmel Paul | Buy | 6,648 | 1.82 | 12,072 |
| 2024-07-22 | Schimmel Paul | Buy | 41,052 | 1.74 | 71,512 |
| 2024-06-05 | Denyes Nancy (General Counsel) | Buy | 5,000 | 1.85 | 9,275 |
| 2024-05-31 | Shukla Sanjay (President and CEO) | Buy | 20,000 | 1.81 | 36,140 |
| 2024-05-31 | Broadfoot Jill Marie (Chief Financial Officer) | Buy | 5,000 | 1.79 | 8,950 |
| 2024-02-06 | Broadfoot Jill Marie (Chief Financial Officer) | Sale | 1,590 | 1.69 | 2,687 |
| 2024-02-05 | Shukla Sanjay (President and CEO) | Option Ex | 10,375 | .00 | 0 |
| 2024-02-05 | Denyes Nancy (General Counsel) | Option Ex | 2,688 | .00 | 0 |
| 2024-02-05 | Broadfoot Jill Marie (Chief Financial Officer) | Option Ex | 3,750 | .00 | 0 |
| 2023-12-12 | Shukla Sanjay (President and CEO) | Buy | 12,000 | 1.18 | 14,136 |
| 2023-12-11 | Shukla Sanjay (President and CEO) | Buy | 3,000 | 1.17 | 3,510 |
| 2023-11-13 | Shukla Sanjay (President and CEO) | Buy | 13,578 | 1.11 | 15,085 |
| 2023-11-10 | Shukla Sanjay (President and CEO) | Buy | 1,422 | 1.14 | 1,618 |
| 2023-07-28 | Shukla Sanjay (President and CEO) | Buy | 15,000 | 2.02 | 30,225 |
| 2023-05-10 | Schimmel Paul (Director) | Buy | 200,000 | 2.25 | 450,000 |
| 2023-04-26 | Lucas Svetlana (Director) | Option Ex | 6,000 | .00 | 0 |
| 2023-04-26 | Gross Jane A (Director) | Option Ex | 6,000 | .00 | 0 |
| 2023-04-26 | Zaknoen Sara (Director) | Option Ex | 6,000 | .00 | 0 |
| 2023-04-26 | Coughlin Timothy (Director) | Option Ex | 6,000 | .00 | 0 |
| 2023-04-26 | Schimmel Paul (Director) | Option Ex | 6,000 | .00 | 0 |
| 2023-02-06 | Broadfoot Jill Marie (Chief Financial Officer) | Sale | 1,566 | 2.36 | 3,695 |
| 2023-02-03 | Shukla Sanjay (President and CEO) | Option Ex | 10,375 | .00 | 0 |
| 2023-02-03 | Denyes Nancy (General Counsel) | Option Ex | 2,688 | .00 | 0 |
| 2023-02-03 | Broadfoot Jill Marie (Chief Financial Officer) | Option Ex | 3,750 | .00 | 0 |
| 2022-11-21 | Shukla Sanjay (President and CEO) | Buy | 10,000 | 2.14 | 21,410 |
| 2022-07-01 | Shukla Sanjay (President and CEO) | Buy | 15,000 | 2.88 | 43,170 |
| 2022-01-13 | Broadfoot Jill Marie (Chief Financial Officer) | Buy | 1,923 | 6.75 | 12,980 |
| 2022-01-07 | Shukla Sanjay (President and CEO) | Buy | 5,000 | 6.76 | 33,805 |
| 2021-11-15 | Shukla Sanjay (President and CEO) | Buy | 2,500 | 8.57 | 21,437 |
| 2021-09-20 | Schimmel Paul (Director) | Buy | 250,000 | 8.00 | 2,000,000 |
| 2021-05-21 | Clarke John K (Director) | Sale | 2,500 | 4.34 | 10,850 |
| 2021-05-18 | Shukla Sanjay (President and CEO) | Buy | 10,000 | 4.01 | 40,100 |
| 2021-05-18 | Schimmel Paul (Director) | Buy | 50,000 | 3.98 | 199,000 |
| 2021-02-09 | Shukla Sanjay (President and CEO) | Sale | 778 | 7.66 | 5,959 |
| 2021-02-09 | Broadfoot Jill Marie (Chief Financial Officer) | Sale | 390 | 7.66 | 2,987 |
| 2021-02-06 | Shukla Sanjay (President and CEO) | Option Ex | 1,785 | .00 | 0 |
| 2021-02-06 | Broadfoot Jill Marie (Chief Financial Officer) | Option Ex | 892 | .00 | 0 |
| 2020-09-02 | Clarke John K (Director) | Sale | 7,260 | 4.01 | 29,112 |
| 2020-08-28 | Clarke John K (Director) | Sale | 100 | 4.00 | 400 |
| 2020-08-27 | Clarke John K (Director) | Sale | 5,440 | 4.09 | 22,249 |
| 2020-08-26 | Clarke John K (Director) | Sale | 2,200 | 4.30 | 9,451 |
| 2020-06-19 | Shukla Sanjay (President and CEO) | Buy | 6,000 | 4.27 | 25,619 |
| 2020-06-19 | Broadfoot Jill Marie (Chief Financial Officer) | Buy | 1,850 | 4.22 | 7,806 |
| 2020-05-20 | Denyes Nancy (General Counsel) | Sale | 322 | 3.62 | 1,165 |
| 2020-05-20 | Schimmel Paul (Director) | Sale | 8,447 | 3.64 | 30,738 |
| 2020-05-16 | Denyes Nancy (General Counsel) | Option Ex | 892 | .00 | 0 |
| 2020-02-10 | Schimmel Paul (Director) | Buy | 254,000 | 4.25 | 1,079,500 |
| 2020-02-07 | Shukla Sanjay (President and CEO) | Sale | 745 | 4.03 | 3,002 |
| 2020-02-07 | Broadfoot Jill Marie (Chief Financial Officer) | Sale | 375 | 4.03 | 1,511 |
| 2020-02-06 | Shukla Sanjay (President and CEO) | Option Ex | 1,786 | .00 | 0 |
| 2020-02-06 | Broadfoot Jill Marie (Chief Financial Officer) | Option Ex | 893 | .00 | 0 |
| 2019-05-17 | Krueger Nancy (General Counsel) | Sale | 4,651 | .45 | 2,092 |
| 2019-05-16 | Krueger Nancy (General Counsel) | Option Ex | 12,500 | .00 | 0 |
| 2018-12-21 | Mendlein John (Director) | Buy | 195,000 | .42 | 82,680 |
| 2018-12-20 | Mendlein John (Director) | Buy | 50,000 | .41 | 20,650 |
| 2018-11-26 | Schimmel Paul (Director) | Buy | 147,225 | .54 | 79,795 |
| 2018-09-20 | Broadfoot Jill Marie (Chief Financial Officer) | Buy | 38,000 | .83 | 31,730 |
| 2018-09-19 | Broadfoot Jill Marie (Chief Financial Officer) | Buy | 26,000 | .81 | 21,112 |
| 2018-09-14 | Broadfoot Jill Marie (Chief Financial Officer) | Buy | 26,000 | .73 | 19,058 |
| 2018-09-04 | Schimmel Paul (Director) | Buy | 20,749 | .76 | 15,706 |
| 2018-08-31 | Schimmel Paul (Director) | Buy | 22,000 | .72 | 15,752 |
| 2018-08-30 | Schimmel Paul (Director) | Buy | 89,275 | .76 | 67,491 |
| 2018-08-29 | Schimmel Paul (Director) | Buy | 75,136 | .72 | 54,097 |
| 2018-05-31 | Amanullah Ashraf (See Remarks) | Option Ex | 3,333 | .00 | 0 |
| 2018-05-18 | Schimmel Paul (Director) | Buy | 150,000 | 1.00 | 149,400 |
| 2018-05-16 | Ecor1 Capital Fund Qualified, L.p. | Sale | 2,733,231 | .81 | 2,216,650 |
| 2018-05-15 | Ecor1 Capital Fund Qualified, L.p. | Sale | 121,294 | 1.43 | 173,086 |
| 2018-05-14 | Ecor1 Capital Fund Qualified, L.p. | Sale | 354,791 | 1.72 | 609,176 |
| 2018-02-08 | Amanullah Ashraf (See Remarks) | Sale | 1,402 | 3.40 | 4,766 |
| 2018-02-08 | Blake John T (Senior Vice President, Finance) | Sale | 1,402 | 3.40 | 4,766 |
| 2018-02-07 | Amanullah Ashraf (See Remarks) | Option Ex | 3,334 | .00 | 0 |
| 2018-02-07 | Blake John T (Senior Vice President, Finance) | Option Ex | 3,334 | .00 | 0 |
| 2017-11-13 | Ecor1 Capital Fund Qualified, L.p. | Sale | 1,083 | 3.95 | 4,277 |
| 2017-11-10 | Ecor1 Capital Fund Qualified, L.p. | Sale | 5,860 | 4.00 | 23,445 |
| 2017-11-09 | Ecor1 Capital Fund Qualified, L.p. | Sale | 5,819 | 4.15 | 24,148 |
| 2017-11-08 | Ecor1 Capital Fund Qualified, L.p. | Sale | 1,070 | 4.30 | 4,601 |
| 2017-11-01 | Ecor1 Capital Fund Qualified, L.p. | Buy | 24,728 | 4.80 | 118,694 |
| 2017-10-01 | Ecor1 Capital Fund Qualified, L.p. | Buy | 4,879 | 5.05 | 24,638 |
| 2017-08-31 | Mendlein John (CEO and Director) | Buy | 37,736 | 2.65 | 100,000 |
| 2017-08-31 | Schimmel Paul (Director) | Buy | 94,336 | 2.65 | 249,990 |
| 2017-04-24 | Mendlein John (CEO and Director) | Buy | 124 | 3.00 | 372 |
| 2017-04-20 | Mendlein John (CEO and Director) | Buy | 1,552 | 3.00 | 4,656 |
| 2017-04-18 | Mendlein John (CEO and Director) | Buy | 1,000 | 3.00 | 3,000 |
| 2016-12-21 | Schimmel Paul (Director) | Buy | 10,000 | 2.28 | 22,820 |
| 2016-12-20 | Amanullah Ashraf (Vice President, Manufacturing) | Buy | 11,000 | 2.25 | 24,750 |
| 2016-12-20 | Schimmel Paul (Director) | Buy | 15,000 | 2.27 | 34,110 |
| 2016-12-19 | Mendlein John (CEO and Director) | Buy | 69,000 | 2.20 | 151,662 |
| 2016-12-16 | Schimmel Paul (Director) | Buy | 10,000 | 2.40 | 23,969 |
| 2016-12-15 | Schimmel Paul (Director) | Buy | 40,000 | 2.50 | 99,920 |
| 2016-05-11 | Matsuoka Grove (See Remarks) | Buy | 10,000 | 3.03 | 30,299 |
| 2016-05-09 | Matsuoka Grove (See Remarks) | Buy | 2,412 | 3.08 | 7,428 |
| 2016-04-14 | Schimmel Paul (Director) | Buy | 66,219 | 4.18 | 276,927 |
| 2016-04-13 | Schimmel Paul (Director) | Buy | 9,835 | 3.85 | 37,864 |
| 2016-04-12 | Schimmel Paul (Director) | Buy | 9,127 | 3.73 | 34,007 |
| 2016-04-11 | Schimmel Paul (Director) | Buy | 32,659 | 3.52 | 114,959 |
| 2016-04-08 | Schimmel Paul (Director) | Buy | 85,000 | 3.22 | 273,615 |
| 2016-04-07 | Schimmel Paul (Director) | Buy | 40,000 | 3.19 | 127,600 |
| 2016-04-06 | Schimmel Paul (Director) | Buy | 25,000 | 3.20 | 80,000 |
| 2016-04-05 | Mendlein John (CEO and Director) | Buy | 5,000 | 3.54 | 17,675 |
| 2016-04-05 | Schimmel Paul (Director) | Buy | 25,000 | 3.52 | 88,125 |
| 2015-05-12 | Deerfield Private Design Fund Iii, L.p. | Buy | 50,000 | 14.00 | 700,000 |
| 2015-05-12 | Mehra Anand (10% Owner) | Buy | 320,000 | 14.00 | 4,480,000 |
| 2015-05-12 | Akkaraju Srinivas (Director) | Buy | 320,000 | 14.00 | 4,480,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of ATYR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Atyr Pharma Inc (symbol ATYR, CIK number 1339970) see the Securities and Exchange Commission (SEC) website.